These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9210757)

  • 21. L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.
    Ritsner MS; Miodownik C; Ratner Y; Shleifer T; Mar M; Pintov L; Lerner V
    J Clin Psychiatry; 2011 Jan; 72(1):34-42. PubMed ID: 21208586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of atypical antipsychotic medications in the treatment of psychosis.
    White DL
    Kans Nurse; 2003; 78(10):1-2. PubMed ID: 14746070
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical antipsychotics cause an acute increase in cutaneous hand blood flow in patients with schizophrenia and schizoaffective disorder.
    Blessing E; Kader L; Arpandy R; Ootsuka Y; Blessing WW; Pantelis C
    Aust N Z J Psychiatry; 2011 Aug; 45(8):646-53. PubMed ID: 21870922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotensin, schizophrenia, and antipsychotic drug action.
    Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
    McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
    J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
    Kinkead B; Nemeroff CB
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin, schizophrenia, and common sense.
    Skrabanek P
    Am J Psychiatry; 1983 May; 140(5):658. PubMed ID: 6133464
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.
    Reutfors J; Brandt L; Stephansson O; Kieler H; Andersen M; Bodén R
    J Clin Psychopharmacol; 2013 Dec; 33(6):759-65. PubMed ID: 24126686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Psychoeducation on Knowledge of and Attitude Toward Medications in Clients With Schizophrenia and Schizoaffective Disorders.
    Choe K; Sung BJ; Kang Y; Yoo SY
    Perspect Psychiatr Care; 2016 Apr; 52(2):113-9. PubMed ID: 25640073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.
    Spellmann I; Riedel M; Städtler J; Zill P; Obermeier M; Cerovecki A; Dehning S; Schennach R; Epple M; Opgen-Rhein M; Müller N; Bondy B; Möller HJ; Musil R
    Cogn Neuropsychiatry; 2017 Jul; 22(4):280-297. PubMed ID: 28470106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
    Nolan KA; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome LL; McEvoy J; Lieberman JA
    J Psychiatr Res; 2005 Jan; 39(1):109-15. PubMed ID: 15504429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia.
    Sasayama D; Hattori K; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    Schizophr Res; 2012 Aug; 139(1-3):201-6. PubMed ID: 22742979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
    Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J
    BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder.
    Elie D; Poirier M; Chianetta J; Durand M; Grégoire C; Grignon S
    J Psychopharmacol; 2010 Jul; 24(7):1037-44. PubMed ID: 19164494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes toward menstruation in females with schizophrenia or schizoaffective disorders in Taiwan.
    Liang HY; Lee LW; Kelsen BA; Hsu SC; Liu CY; Chen CY
    Climacteric; 2013 Dec; 16(6):682-8. PubMed ID: 23205628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.